Production (Stage)
Cannara Biotech Inc.
LOVFF
$0.9114
$0.00730.81%
OTC PK
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | 38.18% | -60.11% | 183.00% | 157.88% | -266.22% |
| Total Depreciation and Amortization | 1.17% | -12.59% | 16.36% | 2.57% | -8.55% |
| Total Amortization of Deferred Charges | 17.36% | 62.42% | -- | -- | -- |
| Total Other Non-Cash Items | -11.79% | 135.97% | -190.77% | -128.85% | 365.09% |
| Change in Net Operating Assets | -2,709.07% | 242.07% | -95.84% | 602.40% | 88.69% |
| Cash from Operations | -142.01% | 82.27% | -26.69% | 54.30% | 258.75% |
| Capital Expenditure | -15.98% | -145.74% | 84.08% | -171.52% | 58.99% |
| Sale of Property, Plant, and Equipment | -- | -73.81% | -99.45% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 71.67% | -11.48% | 16.55% | -13.68% | 25.10% |
| Cash from Investing | -14.38% | -167.83% | 54.02% | 13.42% | 60.01% |
| Total Debt Issued | -- | -- | -100.00% | 120.00% | -60.00% |
| Total Debt Repaid | 72.92% | -4.75% | 81.00% | -437.69% | -7.40% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | 98.42% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -19.15% | 9.95% | -333.50% | 85.56% | -17.71% |
| Cash from Financing | -18.68% | 36.33% | -51.47% | 13.75% | -481.79% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -237.45% | 213.54% | -50.71% | 368.44% | 130.60% |